Eastland Medical Systems Receive Regulatory Approval for Anti-Malaria Treatment

Published: Jan 21, 2008

Perth, Jan 21, 2008 (ABN Newswire) - Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.

Back to news